http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
송숙희(Song, Suk-Hee),백주원(Back, Ju-Won),한인선(Han, In-Seon),김은혜(Kim, Eun-Hye),변년임(Byun, Nyeon-Im),조은미(Cho, Eun-Mi),안태사(An, Ta-Sea),홍희정(Hong, Hui-Joeng) 기본간호학회 2021 기본간호학회지 Vol.28 No.2
Purpose: To assess characteristics the application of mobile medication system and medication administration error (MAE) alerts in a general hospital. Methods: The subject hospital adopted a mobile medication system in 2016. All medication administrations in the general wards and ICUs were automatically recorded in real-time using identification barcodes, drug barcodes, and hand-held point-of-care devices. MAE alert logs were recorded from April 1st 2017 to March 31st 2018. For this study analysis was done using Pearson’s chi-squared test for potentially related factors of MAE alerts included administration time, order type, medication route, and length of nurse’s employment. Results: The total number of medications during the period of this study was 3,227,990. Among them, 2,698,317 medication doses were recorded, resulting in the system application rate of 83.6%. The system application rate was significantly correlated with all factors related to potential MAE alters. In this study 23,314 MAE alerts(0.9% of the total medication doses) were identified. The MAE alerts were related to new (OR=2.26, p<.001) and emergency (OR=2.25, p<.001) orders, and administration at a non-standard time (OR=2.032, p<.001). Medication route (p<.001), and nurse’s employment duration(p<.001) were also related. Conclusion: A mobile medication system contributes to improving patient safety by preventing potential MAEs. The MAE alerts were related to administration time, order type, medication route, and duration of nurse’s employment. In order to prevent medication administration errors, it is necessary to standardize the process of medication and create an environment in which medication administration can be performed in a planned situation.
이은준,심미영,송숙희,이미미,김혜미,강봉선,양은진,임지영,김진아,이미나,Lee, Eun-Joon,Shim, Mi-Young,Song, Suk-Hee,Lee, Mi-Mi,Kim, Hye-Mi,Kang, Bong-Sun,Yang, Eun-Jeen,Lim, Ji-Young,Kim, Jin-A,Lee, Mi-Na 한국중환자간호학회 2010 중환자간호학회지 Vol.3 No.2
Purpose: The purpose of this study was to examine the frequency and the course of delirium, and identify risk factors for the development of delirium in surgical intensive care unit (SICU). Methods: Subjects older than 19 years admitted to the SICU were recruited. After informed written consent, enrolled subjects had baseline cognitive and functional assessments. Subjects were assessed daily for delirium using the Confusion Assessment Method-ICU (CAM-ICU). Results: During the study period, 110 patients were enrolled. The overall incidence of delirium was 20% (22/110). The average time to onset of delirium was 3.04(${\pm}1.25$) days. Several variables were associated with an increased risk of delirium including older age (p<.05), higher admission APACHE II score (p<.001), use of opioid and analgesics (p<.01), using physical restraints (p<.001), and intraoperative hypotension (p<.05). In a multivariate logistic regression model, using physical restraints (p<.001), intraoperative hypotension (p<.05), and older age (p<.05) remained significant predictors of the delirium development. Conclusion: Using physical restraints, intraoperative hypotension and older age was strongly associated with development of delirium in the SICU. Prevention measures need to focus on identifying patients at higher risk for delirium development.
간장 ( 肝臟 ) 및 담도 ( 膽道 ) : 심한 재발성 간염을 일으킨 만성 B형 간염 환자에서의 인터페론의 치료효과
유재영(Jae Young Yoo),박충기(Choong Kee Park),김학양(Hak Yang Kim),임규성(Kyu Sung Lim),송숙희(Sook Hee Song),김규태(Kyu Tae Kim),박승욱(Seung Wook Park),조호준(Ho Jun Cho),김종혁(Jong Hyeok Kim),박신성(Shin Sung Park),김동준(Dong Ju 대한소화기학회 1991 대한소화기학회지 Vol.23 No.2
N/A We treated nine patients with chronic hepatitis B with recombinant interferon alpha who showed severe exacerbation of hepatitis activity. All had HBsAg for at least 5 years, and had multiple episodes of elevated serum transaminase levels. They were all men, ages 26~55 (mean 41) years. The range of serum AST was 131~885 (mean 326) U/L, the ALT 62~610 (mean 303) U/L, the bilirubin 1.3~37.3 (mean 12.0) mg/dl, total protein 4.4~8.7 (mean 6.6) g/dl, and the albumin 2.4~4.4 (mean 3, 1) g/dl. Seven patients had ascites by ultrasonogram and three showed clinical evidence of grade I hepatic encephalopathy. The needle biopsy of the liver was avalilable in 6 patients, and showed severe chronic active hepatitis with established macronodular cirrhosis. Interferon was administered in a dose of three million units subcutaneously every other day for 6 months and followed up for 12 to 24 months. The results were as follows: 1) Serum transaminases: The serum transaminases became normal in 8 patients during therapy but incresed again during the follow-up in two. One patient, whose transaminses decreased temporalily with therapy, died at the 45th days of therapy due to hepatic failure. 2) Serum bilirubin: In 7 patients with hyperbilirubinemia (2.4~37.3mg/dl), the bilirubin became normal in 5 during therapy, but incresed again in 2 during the follow up-period. In one dead case, the elevated bilirubin decreased transiently but increased again during treatment. 3) Serum albumin: In 4 patients with hypoalbuminemia, the serum albumin became normal in two, and in one became transiently elevated but decreased again during treatment. 4) Prothrombin time: In 6 patients whose prothrornbin time was prolonged, it became normal in 5 except in one patient who died. 5) Ascites: In 7 patients with ascites, the ascites disappeared in 3 during the treatment and in 3 during the follow-up period. But the ascites developed again in 2 of 6 patients. There was no change of ascites in an expired case. 6) Serum HBeAg and HBV-DNA: In 7 patients with serum HBeAg and HBV-DNA, these markers became negative in 5 during treatment, but positive again in one patient during the follow-up period. 7) Symptoms of hepatic encephalopathy: Among 3 patients who developed hepatic encephalopathy (Grade 1) before therapy, 2 patients were improved during therapy. In conclusion, this study, although not adequately controlled, suggested that alpha intreferon therapy may be effective and safe in patients with chronic hepatitis B who showed severe exacerbation of disease activity. A prospective controlled study is needed to assess the role of interferon in these patients.
이준호 ( Jun Ho Lee ),김의창 ( Eui Chang Kim ),임용석 ( Yong Seok Lim ),이현석 ( Hyun Suk Lee ),송숙희 ( Sook Hee Song ),김수현 ( Su Hyun Kim ),김혜옥 ( Hye Ok Kim ) 대한내과학회 2016 대한내과학회지 Vol.91 No.1
Thymic cysts are uncommon benign lesions in the anterior mediastinum. We here describe a 55-year-old male with spontaneous thymic cyst hemorrhage manifesting as a rapidly enlarging mediastinal mass that was resected completely with video-assisted thoracoscopic surgery. To the best of our knowledge, this is the first report of a spontaneous thymic cyst hemorrhage in Korea. In cases of rapidly enlarging mediastinal masses, spontaneous thymic cyst hemorrhage should be considered as a differential diagnosis. (Korean J Med 2016;91:62-65)
유재영(Jae Young Yoo),신호균(Ho Kyun shin),고순희(Soon Hee Koh),김종혁(Jong Hyouk Kim),송숙희(Sook Hee Song),김규태(Kyu Tae Kim),김학양(Ho Kyun Shin),김진한(Jin Han Kim) 대한소화기학회 1990 대한소화기학회지 Vol.22 No.4
Primary biliary cirrhosis is a relatively common liver disease with cholestasis in Western countries, especially in the middle aged women. The sex distributian of this disease between male to female was 1/9. 1n the Korean literatures, there were only 4 casea reported in female, not in male. We report a case of primary biliary cirrhosis with a review of literatures in a 62-year-old man whose serum bilirubin and alkaline phosphatase were persistently elevated.